We adhere to high ethical standards and strive to maintain an environment of mutual respect and honesty with our clients and among ourselves.
Carter, DeLuca & Farrell LLP, a leader in intellectual property law, provides cost-effective services to clients from around the world, protecting innovations in a wide range of technologies.
Throughout the phases of product or brand development, we form a critical part of our clients’ development teams to provide preparation, prosecution and clearance services to maximize protection while navigating through freedom-to-operate challenges. We also provide extensive IP due diligence services and IP asset assimilation to help our clients achieve their business objectives.
GlaxoSmithKline and SmithKline Beecham (collectively, “GSK”) charged Teva Pharmaceuticals with infringement of GSK’s Reissue Patent No. RE40,000 (“the ’000 patent”) directed to carvedilol...
Biogen MA, Inc. sued EMD Serono, Inc. and Pfizer alleging contributory and induced infringement of Biogen’s U.S. Patent Number 7,588,755 by the sale...
Voip-Pal.com, Inc. owns U.S. Patent Nos. 8,542,815 and 9,179,005, both of which are titled “Producing Routing Messages for Voice Over IP Communications” and...